BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Troost EGC, Wink KCJ, Roelofs E, Simone CB 2nd, Makocki S, Löck S, van Kollenburg P, Dechambre D, Minken AWH, van der Stoep J, Avery S, Jansen N, Solberg T, Bussink J, de Ruysscher D. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO in silico study. Br J Radiol 2020;93:20190879. [PMID: 31804145 DOI: 10.1259/bjr.20190879] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Held KD, Lomax AJ, Troost EGC. Proton therapy special feature: introductory editorial. Br J Radiol 2020;93:20209004. [PMID: 32081045 DOI: 10.1259/bjr.20209004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hunter B, Crockett C, Faivre-Finn C, Hiley C, Salem A. Re-Irradiation of Recurrent Non-Small Cell Lung Cancer. Semin Radiat Oncol 2021;31:124-32. [PMID: 33610269 DOI: 10.1016/j.semradonc.2020.11.009] [Reference Citation Analysis]
3 Troost EGC, Menkel S, Tschiche M, Thiele J, Jaster M, Haak D, Kunath D. Towards online adaptive proton therapy: first report of plan-library-based plan-of-the-day approach. Acta Oncol 2021;:1-4. [PMID: 34697985 DOI: 10.1080/0284186X.2021.1994154] [Reference Citation Analysis]
4 Levy A, Botticella A, Le Péchoux C, Faivre-Finn C. Thoracic radiotherapy in small cell lung cancer-a narrative review. Transl Lung Cancer Res 2021;10:2059-70. [PMID: 34012814 DOI: 10.21037/tlcr-20-305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Doyen J, Aloi D, Groulier A, Vidal M, Lesueur P, Calugaru V, Bondiau PY. Role of proton therapy in reirradiation and in the treatment of sarcomas. Cancer Radiother 2021:S1278-3218(21)00123-2. [PMID: 34284969 DOI: 10.1016/j.canrad.2021.06.024] [Reference Citation Analysis]
6 Grambozov B, Stana M, Kaiser B, Karner J, Gerum S, Ruznic E, Zellinger B, Moosbrugger R, Studnicka M, Fastner G, Sedlmayer F, Zehentmayr F. High Dose Thoracic Re-Irradiation and Chemo-Immunotherapy for Centrally Recurrent NSCLC. Cancers 2022;14:573. [DOI: 10.3390/cancers14030573] [Reference Citation Analysis]
7 Rulach R, Ball D, Chua KLM, Dahele M, De Ruysscher D, Franks K, Gomez D, Guckenberger M, Hanna GG, Louie AV, Moghanaki D, Palma DA, Peedell C, Salem A, Siva S, Videtic GMM, Chalmers AJ, Harrow S. An International Expert Survey on the Indications and Practice of Radical Thoracic Reirradiation for Non-Small Cell Lung Cancer. Adv Radiat Oncol 2021;6:100653. [PMID: 33851065 DOI: 10.1016/j.adro.2021.100653] [Reference Citation Analysis]
8 Yang WC, Hsu FM, Chen YH, Shih JY, Yu CJ, Lin ZZ, Lu SH, Yang JC, Cheng AL, Kuo SH. Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancer. Clin Transl Radiat Oncol 2020;22:76-82. [PMID: 32280792 DOI: 10.1016/j.ctro.2020.03.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]